✦ LIBER ✦

Pharmacokinetics, Pharmacodynamics and Tolerability of Opicapone, a Novel Catechol-O-Methyltransferase Inhibitor, in Healthy Subjects

✍ Scribed by Luis Almeida, José Francisco Rocha, Amílcar Falcão, P. Nuno Palma, Ana I. Loureiro, Roberto Pinto, Maria João Bonifácio, Lyndon C. Wright, Teresa Nunes, Patrício Soares-da-Silva

Book ID: 118307198
Publisher: Springer International Publishing AG
Year: 2012
Tongue: English
Weight: 699 KB
Volume: 52
Category: Article
ISSN: 0312-5963
DOI: 10.1007/s40262-012-0024-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2.244 PHARMACOKINETICS, PHARMACODYNAMICS

2.244 PHARMACOKINETICS, PHARMACODYNAMICS AND TOLERABILITY OF OPICAPONE, A NOVEL COMT INHIBITOR, DURING FIRST ADMINISTRATION TO HEALTHY MALE SUBJECTS

✍ T. Nunes; J.F. Rocha; R. Pinto; R. Machado; L.C. Wright; A. Falcao; L. Almeida; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 52 KB

2.245 PHARMACOKINETICS, PHARMACODYNAMICS

2.245 PHARMACOKINETICS, PHARMACODYNAMICS AND TOLERABILITY OF OPICAPONE, A NOVEL COMT INHIBITOR, DURING MULTIPLE RISING DOSE REGIMENS IN HEALTHY MALE SUBJECTS

✍ J.F. Rocha; T. Nunes; M. Vaz-da-Silva; R. Machado; L.C. Wright; A. Falcao; L. Al 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Opicapone: a short lived and very long a

Opicapone: a short lived and very long acting novel catechol-O-methyltransferase inhibitor following multiple dose administration in healthy subjects

✍ Rocha, José Francisco; Almeida, Luis; Falcão, Amílcar; Palma, P. Nuno; Loureiro, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 603 KB

2.242 BRAIN AND PERIPHERAL LEVODOPA PHAR

2.242 BRAIN AND PERIPHERAL LEVODOPA PHARMACOKINETICS IN THE CYNOMOLGUS MONKEY FOLLOWING ADMINISTRATION OF OPICAPONE, A NOVEL CATECHOL-O-METHYLTRANSFERASE INHIBITOR

✍ M.J. Bonifacio; J.S. Sutcliffe; L Torrão; L Wright; P. Soares-da-Silva 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Integrated pharmacokinetics and pharmaco

Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans*

✍ Dingemanse, Jasper; Jorga, Karin M.; Schmitt, Monique; Gieschke, Ronald; Fottele 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 908 KB

Object&z-To assess the tolerability, pharmacokinetics and pharmacodynamics of single oral doses of the novel catechol-0-methyltransferase (COMT) inhibitor tolcapone in healthy volunteers. Metbuuk In this double-blind, placebo-controlled, ascending-single-dose study, doses of 5 to 800 mg tolcapone w

The pharmacokinetics, pharmacodynamics a

The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects

✍ Joachim Stangier; Karin Rathgen; Hildegard Stähle; Dietmar Gansser; Willy Roth 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB